LOXL2 and breast cancer: Although the expression of LOXL2 was determined to be lower than that determined in MDA-MB-231 cells, LOXL2-positive breast cancer cells [13], SW480 cells showed considerably higher migratory potential than LOXL2-negative cells, in migration assay and wound healing assay (Figure 1C and Supplementary Figure 1A).